All Stories

  1. Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery disease
  2. Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer’s Disease
  3. TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress
  4. Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up
  5. Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes
  6. Leptin/adiponectin ratio predicts poststroke neurological outcome
  7. serum paraoxonase in alzheimer and MCI
  8. Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis
  9. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke
  10. TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis
  11. Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways
  12. N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
  13. Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study
  14. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding
  15. Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study
  16. CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
  17. Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms
  18. Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry
  19. Timing of Serum Active MMP-9 and MMP-2 Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage
  20. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis